<VariationArchive RecordType="classified" VariationID="833058" VariationName="NC_000023.11:g.(?_18929208)_(18983952_?)del" VariationType="Deletion" Accession="VCV000833058" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2020-04-15" MostRecentSubmission="2020-04-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="821579" VariationID="833058">
      <GeneList>
        <Gene Symbol="PHKA2" FullName="phosphorylase kinase regulatory subunit alpha 2" GeneID="5256" HGNC_ID="HGNC:8926" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xp22.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="18892298" stop="18984114" display_start="18892298" display_stop="18984114" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="18910415" stop="19002479" display_start="18910415" display_stop="19002479" Strand="-" />
          </Location>
          <OMIM>300798</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000023.11:g.(?_18929208)_(18983952_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xp22.13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" innerStart="18947326" innerStop="19002070" display_start="18947326" display_stop="19002070" variantLength="54745" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.(?_18947326)_(19002070_?)del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.(?_18947326)_(19002070_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000023.11:g.(?_18929208)_(18983952_?)del AND Glycogen storage disease IXa1" Accession="RCV001033518" Version="1">
        <ClassifiedConditionList TraitSetID="7454">
          <ClassifiedCondition DB="MedGen" ID="C3694531">Glycogen storage disease IXa1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-09-09" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-09-09" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-04-15" MostRecentSubmission="2020-04-15">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="7454" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2237" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GSD VIII</ElementValue>
                <XRef Type="MIM" ID="306000" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogen storage disease 8</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogenosis type 8</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hepatic phosphorylase kinase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Phosphorylase kinase deficiency of liver</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Glycogen storage disease IXa1</ElementValue>
                <XRef ID="MONDO:0010598" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">LIVER GLYCOGENOSIS, X-LINKED, TYPE I</ElementValue>
                <XRef Type="MIM" ID="306000" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PYKL</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">GSD8</ElementValue>
                <XRef Type="MIM" ID="306000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">GSD9A1</ElementValue>
                <XRef Type="MIM" ID="306000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">XLG1</ElementValue>
                <XRef Type="MIM" ID="306000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">XLG2</ElementValue>
                <XRef ID="306000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Phosphorylase kinase (PhK) deficiency causing glycogen storage disease type IX (GSD IX) results from deficiency of the enzyme phosphorylase b kinase, which has a major regulatory role in the breakdown of glycogen. The two types of PhK deficiency are liver PhK deficiency (characterized by early childhood onset of hepatomegaly and growth restriction, and often, but not always, fasting ketosis and hypoglycemia) and muscle PhK deficiency, which is considerably rarer (characterized by any of the following: exercise intolerance, myalgia, muscle cramps, myoglobinuria, and progressive muscle weakness). While symptoms and biochemical abnormalities of liver PhK deficiency were thought to improve with age, it is becoming evident that patients need to be monitored for long-term complications such as liver fibrosis and cirrhosis.</Attribute>
                <XRef ID="NBK55061" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">21634085</ID>
                <ID Source="BookShelf">NBK55061</ID>
              </Citation>
              <XRef ID="264580" DB="Orphanet" />
              <XRef ID="C3694531" DB="MedGen" />
              <XRef ID="MONDO:0010598" DB="MONDO" />
              <XRef Type="MIM" ID="306000" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2358081" SubmissionDate="2020-02-06" DateLastUpdated="2020-04-15" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="7580286|MedGen:C0017927" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001196825" DateUpdated="2020-04-15" DateCreated="2020-04-15" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-09-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant is a gross deletion of the genomic region encompassing exons 1-13 of the PHKA2 gene, which includes the initiator codon. The 5' end of this event is unknown as it extends beyond the assayed region for this gene and therefore may encompass additional genes. The 3' boundary is likely confined to intron 13 of the PHKA2 gene. This is expected to result in an absent or disrupted protein product. This variant has been observed in an individual affected with GSD IXa (Invitae). Loss-of-function variants in PHKA2 are known to be pathogenic (PMID: 7711737, 10330341). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PHKA2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.(?_18947326)_(19002070_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Glycogen storage disease type VIII</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0017927" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6933794</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2358081" TraitType="Disease" MappingType="Name" MappingValue="Glycogen storage disease type VIII" MappingRef="Preferred">
        <MedGen CUI="C3694531" Name="Glycogen storage disease IXa1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

